Literature DB >> 17850194

Deep brain stimulation: indications and evidence.

Erlick A C Pereira1, Alexander L Green, Dipankar Nandi, Tipu Z Aziz.   

Abstract

Deep brain stimulation is a minimally invasive targeted neurosurgical intervention that enables structures deep in the brain to be stimulated electrically by an implanted pacemaker. It has become the treatment of choice for Parkinson's disease, refractory to, or complicated by, drug therapy. Its efficacy has been demonstrated robustly by randomized, controlled clinical trials, with multiple novel brain targets having been discovered in the last 20 years. Multifarious clinical indications for deep brain stimulation now exist, including dystonia and tremor in movement disorders; depression, obsessive-compulsive disorder and Tourette's syndrome in psychiatry; epilepsy, cluster headache and chronic pain, including pain from stroke, amputation, trigeminal neuralgia and multiple sclerosis. Current research argues for novel indications, including hypertension and orthostatic hypotension. The development, principles, indications and effectiveness of the technique are reviewed here. While deep brain stimulation is a standard and widely accepted treatment for Parkinson's disease after 20 years of experience, in chronic pain it remains restricted to a handful of experienced, specialist centers willing to publish outcomes despite its use for over 50 years. Reasons are reviewed and novel approaches to appraising clinical evidence in functional neurosurgery are suggested.

Entities:  

Mesh:

Year:  2007        PMID: 17850194     DOI: 10.1586/17434440.4.5.591

Source DB:  PubMed          Journal:  Expert Rev Med Devices        ISSN: 1743-4440            Impact factor:   3.166


  28 in total

1.  Model-driven therapeutic treatment of neurological disorders: reshaping brain rhythms with neuromodulation.

Authors:  Julien Modolo; Alexandre Legros; Alex W Thomas; Anne Beuter
Journal:  Interface Focus       Date:  2010-11-17       Impact factor: 3.906

Review 2.  The autonomic effects of deep brain stimulation--a therapeutic opportunity.

Authors:  Jonathan A Hyam; Morten L Kringelbach; Peter A Silburn; Tipu Z Aziz; Alexander L Green
Journal:  Nat Rev Neurol       Date:  2012-06-12       Impact factor: 42.937

3.  Outcomes remain ambivalent for deep brain stimulation and epilepsy.

Authors:  Elinor Ben-Menachem
Journal:  Epilepsy Curr       Date:  2008 Sep-Oct       Impact factor: 7.500

4.  Electrical stimulation therapies for CNS disorders and pain are mediated by competition between different neuronal networks in the brain.

Authors:  Carl L Faingold
Journal:  Med Hypotheses       Date:  2008-08-30       Impact factor: 1.538

5.  Dynamics of the subthalamo-pallidal complex in Parkinson's disease during deep brain stimulation.

Authors:  J Modolo; J Henry; A Beuter
Journal:  J Biol Phys       Date:  2008-08-01       Impact factor: 1.365

Review 6.  Role of radiology in central nervous system stimulation.

Authors:  D P Minks; E A C Pereira; V E L Young; K M Hogarth; G Quaghebeur
Journal:  Br J Radiol       Date:  2015-02-25       Impact factor: 3.039

Review 7.  Neuropathic pain and deep brain stimulation.

Authors:  Erlick A C Pereira; Tipu Z Aziz
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

Review 8.  ["Psychosurgery" and deep brain stimulation with psychiatric indication. Current and historical aspects].

Authors:  M Arends; H Fangerau; G Winterer
Journal:  Nervenarzt       Date:  2009-07       Impact factor: 1.214

9.  [Neuromodulation in cluster headache. Clinical follow-up after deep brain stimulation in the posterior hypothalamus for chronic cluster headache, case report--Part II].

Authors:  D Rasche; D Klase; V M Tronnier
Journal:  Schmerz       Date:  2008-02       Impact factor: 1.107

Review 10.  [Anesthesiological aspects of deep brain stimulation : special features of implementation and dealing with brain pacemaker carriers].

Authors:  M Seemann; N Zech; M Lange; J Hansen; E Hansen
Journal:  Anaesthesist       Date:  2013-07       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.